Combining metformin with α-PD-1 antibody immunotherapy for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis-related hepatocellular carcinoma

Ähnliche Einträge

• Alcoholic and non-alcoholic steatohepatitis
  von: Neuman, Manuela G., et al.
  Veröffentlicht: (2014)
• Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
  von: Pinyol i Agelet, Roser, et al.
  Veröffentlicht: (2021)
• Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
  von: Tannapfel, Andrea, et al.
  Veröffentlicht: (2011)
• Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
  von: Tannapfel, Andrea, et al.
  Veröffentlicht: (2011)
• Impact of type 2 diabetes on oncologic outcomes of hepatocellular carcinomas in non-cirrhotic, non-alcoholic steatohepatitis: a matched-pair analysis
  von: Billeter, Adrian, et al.
  Veröffentlicht: (2021)